Skip to content

Study · Not a test of the peptide alone · 1992

2 results

A thymosin beta 4 ELISA using an antibody against the N terminal fragment thymosin beta 4 [1-14].

Livaniou E, Mihelic M, Evangelatos GP, Haritos A, Voelter W

Journal of immunological methods1 Apr 1992Cited by 15 (Europe PMC)

PMID1564338 (opens in a new tab)DOI10.1016/0022-1759(92)90152-j (opens in a new tab)PepBankPUB-01564338
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin beta-4 (human).

  1. 01LabNot a test of Thymosin beta-4 (human) aloneIn vitro (cell-free)Other

    The antibody against thymosin beta‑4[1-14] used in the thymosin beta‑4 ELISA showed 0.1% cross-reactivity with thymosin beta 9 and had the highest titre.

    In plain wordsIn lab tests, the antibody used in a thymosin beta‑4 ELISA reacted very little with the related peptide thymosin beta 9.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    Not applicableELISA antibody cross-reactivity with thymosin beta 9
    Study

    n: not reported in source

    Competitive ELISA with rabbit anti-thymosin beta 4[1-14] antibody
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Measurements

    cross-reactivity
    0.1%
    thymosin beta 9

    Source sentences

    Summary
    The antibody against thymosin beta 4[1-14] was used in the thymosin beta 4 ELISA, because it showed minimal cross-reactivity (0.1%) with the highly homologous peptide thymosin beta 9 as well as exhibiting the highest titre.

    In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).

  2. 02LabNot a test of Thymosin beta-4 (human) aloneIn vitro (cell-free)Other

    The thymosin beta‑4 ELISA was fast, easy to perform and exhibited good assay characteristics.

    In plain wordsIn lab tests, the thymosin beta‑4 ELISA was fast, easy to run and performed well.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    Not applicableELISA assay characteristics
    Study

    n: not reported in source

    Competitive ELISA with rabbit anti-thymosin beta 4[1-14] antibody
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    The ELISA procedure developed, apart from showing a minimal cross-reaction with thymosin beta 9, was fast, easy to perform and exhibited good assay characteristics.

    In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.